Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AmberHealth vs Avono Health

AmberHealth
Graded #31

Higher grade

vs+24.200000000000003
Avono Health
Graded #361

Lower grade

The verdict

AmberHealth takes it — 82.9/100 to 58.7/100.

AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmberHealth +60
90
30
Dose & formulationAmberHealth +5
80
75
Clinical oversightAvono Health +1
79
80
Labs & monitoringAmberHealth +25
78
53
FulfillmentAmberHealth +15
86
71
Contract termsAmberHealth +35
82
47
AmberHealth · left barAvono Health · right bar

The numbers

MetricAmberHealthAvono Health
WeighScore82.9/10058.7/100
GradeB−C
Scorecard rank#31#361
Semaglutide$100/mo$269/mo (compounded)
Tirzepatide$175/mo$349/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
AmberHealth

Graded #31 · B−

Strengths

  • $100 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Tirzepatide $175
  • Monitoring detail sparse
Avono Health

Graded #361 · C

Strengths

  • Transparent tiered pricing from $179/mo (microdose semaglutide injection)
  • Full compounded range — semaglutide and tirzepatide, injection and oral, microdose and standard
  • Free and discreet shipping; 24/7/365 messaging support; 100% online
  • US-licensed clinicians and pharmacies; bundle discounts at 3/6/12 months

Where it loses points

  • Medications are compounded, not FDA-approved brand-name
  • Compounding pharmacy not publicly named
  • State availability not published
  • Newer brand with limited independent review history

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard